Intrinsiqs

Is United Therapeutics Corporation overvalued?

United Therapeutics Corporation (UTHR) looks overvalued — trading about 27% above its fair value.

Overvalued
Current price $591.17 Fair value $429.99
Price
$591.17
Fair value
$429.99
Current P/E
21.8
Normal P/E
15.9
Market cap
$25.18B
Dividend yield
0.0%
Return on equity
19.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares UTHR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.